Last reviewed · How we verify
Perindopril tert-Butylamine tablets（ACERTIL®）
Perindopril tert-Butylamine tablets（ACERTIL®） is a Small molecule drug developed by Sichuan Haisco Pharmaceutical Group Co., Ltd. It is currently in Phase 1 development.
At a glance
| Generic name | Perindopril tert-Butylamine tablets（ACERTIL®） |
|---|---|
| Sponsor | Sichuan Haisco Pharmaceutical Group Co., Ltd |
| Modality | Small molecule |
| Phase | Phase 1 |
Approved indications
Common side effects
Key clinical trials
- A Study on the Bioequivalence of Perindopril Tert-butylamine Tablets Taken on After Meals in Healthy Subjects (PHASE1)
- A Study on the Bioequivalence of Perindopril Tert-butylamine Tablets Taken on an Empty Stomach in Healthy Subjects (PHASE1)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Perindopril tert-Butylamine tablets（ACERTIL®） CI brief — competitive landscape report
- Perindopril tert-Butylamine tablets（ACERTIL®） updates RSS · CI watch RSS
- Sichuan Haisco Pharmaceutical Group Co., Ltd portfolio CI
Frequently asked questions about Perindopril tert-Butylamine tablets（ACERTIL®）
What is Perindopril tert-Butylamine tablets（ACERTIL®）?
Perindopril tert-Butylamine tablets（ACERTIL®） is a Small molecule drug developed by Sichuan Haisco Pharmaceutical Group Co., Ltd.
Who makes Perindopril tert-Butylamine tablets（ACERTIL®）?
Perindopril tert-Butylamine tablets（ACERTIL®） is developed by Sichuan Haisco Pharmaceutical Group Co., Ltd (see full Sichuan Haisco Pharmaceutical Group Co., Ltd pipeline at /company/sichuan-haisco-pharmaceutical-group-co-ltd).
What development phase is Perindopril tert-Butylamine tablets（ACERTIL®） in?
Perindopril tert-Butylamine tablets（ACERTIL®） is in Phase 1.